Updating results

88 results for Depression in Children and Adolescents

Sort: Relevance | Date

Postnatal care up to 8 weeks after birth (CG37)

This guideline covers the routine postnatal care women and their babies should receive for 6–8 weeks after the birth. It includes advice given on breastfeeding, and the management of common and serious health problems in women and their babies after the birth.

Clinical guideline Published July 2006 Last updated February 2015

Eating disorders: recognition and treatment (NG69)

This guideline covers assessment, treatment, monitoring and inpatient care for children, young people and adults with eating disorders. It aims to improve the care people receive by detailing the most effective treatments for anorexia nervosa, binge eating disorder and bulimia nervosa.

NICE guideline Published May 2017

What is the clinical and cost effectiveness, post-treatment and at longer-term follow‑up, of psychological therapies in children aged 5 to 11 years with mild or moderate to severe depression?

follow‑up, of psychological therapies in children aged 5 to 11 years with mild or moderate to severe depression? Any...

Research recommendation Published October 2019

Borderline personality disorder: recognition and management (CG78)

This guideline covers recognising and managing borderline personality disorder. It aims to help people with borderline personality disorder to manage feelings of distress, anxiety, worthlessness and anger, and to maintain stable and close relationships with others.

Clinical guideline Published January 2009

Child maltreatment: when to suspect maltreatment in under 18s (CG89)

This guideline covers the signs of possible child maltreatment in children and young people aged under 18 years. It aims to raise awareness and help health professionals who are not child protection specialists to identify the features of physical, sexual and emotional abuse, neglect and fabricated or induced illness.

Clinical guideline Published July 2009 Last updated October 2017

Past appeals and decisions

adalimumab, etanercept & infliximab 31 March 2008 TA010 Asthma (children under 5) - inhaler devices 31 August 2000 TA138 Asthma (in...

Published May 2019 Last updated May 2019

Self-harm

Everything NICE has said on assessing and managing self-harm in an interactive flowchart

NICE Pathway Published November 2011 Last updated September 2019

Management of vomiting in children and young people with gastroenteritis: ondansetron (ESUOM34)

Summary of the evidence on ondansetron for the management of vomiting in children and young people with acute gastroenteritis...

Evidence summary Published October 2014

Sexually transmitted infections and under-18 conceptions: prevention (PH3)

This guideline covers one-to-one interventions to prevent sexually transmitted infections (STIs) and under-18 conceptions. The aim is to reduce the transmission of chlamydia and other STIs, including HIV, and reduce the rate of pregnancies among women aged under 18.

Public health guideline Published February 2007

Alcohol-use disorders

Everything NICE has said on preventing, diagnosing and managing alcohol-related disorders in an interactive flowchart

NICE Pathway Published May 2011 Last updated August 2019

Alcohol-use disorders: diagnosis and management (QS11)

This quality standard covers identifying and supporting adults and young people (aged 10 and over) who may have an alcohol problem, and caring for people with alcohol-related health problems, such as alcohol dependence or Wernicke's encephalopathy. It also covers support for their families and carers. It describes high-quality care in priority areas for improvement.

Quality standard Published August 2011

Personality disorders: borderline and antisocial (QS88)

This quality standard covers assessing and managing borderline and antisocial personality disorders. It describes high-quality care in priority areas for improvement.

Quality standard Published June 2015

Obesity prevention (CG43)

This guideline covers preventing children, young people and adults becoming overweight or obese. It outlines how the NHS, local authorities, early years’ settings, schools and workplaces can increase physical activity levels and make dietary improvements among their target populations.

Clinical guideline Published December 2006 Last updated March 2015

Amantadine, oseltamivir and zanamivir for the treatment of influenza (TA168)

Evidence-based recommendations on amantadine (Lysovir, Symmetrel), oseltamivir (Tamiflu) and zanamivir (Relenza) for treating influenza (flu)

Technology appraisal guidance Published February 2009

Epilepsy in adults (QS26)

This quality standard covers diagnosing, treating and managing epilepsy and seizures in adults (aged 18 and older). It describes high-quality care in priority areas for improvement.

Quality standard Published February 2013

Epilepsy

Everything NICE has said on diagnosing and managing the epilepsies in adults and children in primary and secondary care in an interactive flowchart

NICE Pathway Published January 2012 Last updated October 2019

Fellows

Details of former NICE fellows

Published May 2019 Last updated May 2019

Cardiovascular disease prevention (PH25)

This guideline covers the main risk factors linked with cardiovascular disease: poor diet, physical inactivity, smoking and excessive alcohol consumption. It aims to reduce the high incidence of cardiovascular disease. This, in turn, will help prevent other major causes of death and illness, such as type 2 diabetes and many cancers.

Public health guideline Published June 2010

Block scoping reports

This information helps ministers to decide whether or not a technology should be formally referred to NICE for appraisal and whether it should be referred as an MTA or an STA.

Published December 2019 Last updated December 2019

Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis (TA373)

Evidence-based recommendations on abatacept, adalimumab, etanercept and tocilizumab for treating polyarticular juvenile idiopathic arthritis (JIA)

Technology appraisal guidance Published December 2015

Accreditation external advisers

fatigue syndrome, self management blood glucose, intercultural aspects of depression, and prevention of bullying in schools. John...

Published June 2018 Last updated June 2018

Learning disabilities and behaviour that challenges

Everything NICE has said on services, prevention and interventions for people with learning disabilities whose behaviour challenges in an interactive flowchart

NICE Pathway Published May 2015 Last updated October 2019

Physical activity: brief advice for adults in primary care (PH44)

This guideline covers providing brief advice on physical activity to adults in primary care. It aims to improve health and wellbeing by raising awareness of the importance of physical activity and encouraging people to increase or maintain their activity level.

Public health guideline Published May 2013

Smoking: acute, maternity and mental health services (PH48)

This guideline covers helping people to stop smoking in acute, maternity and mental health services. It promotes smokefree policies and services and recommends effective ways to help people stop smoking or to abstain from smoking while using or working in secondary care settings.

Public health guideline Published November 2013

Human growth hormone (somatropin) in adults with growth hormone deficiency (TA64)

Evidence-based recommendations on human growth hormone (somatropin; Genotropin, Humantrope, Norditropin, Saizen) in adults with growth hormone deficiency

Technology appraisal guidance Published August 2003

Excess winter deaths and illness and the health risks associated with cold homes (NG6)

This guideline covers reducing the health risks (including preventable deaths) associated with living in a cold home. It aims to improve the health and wellbeing of people vulnerable to the cold. Improving the temperature in homes, by improving energy efficiency, may also help reduce unnecessary fuel consumption.

NICE guideline Published March 2015

Migalastat for treating Fabry disease (HST4)

Evidence-based recommendations on migalastat (Galafold) for treating Fabry disease in people over 16

Highly specialised technologies guidance Published February 2017

Scleroderma: oral mycophenolate (ESUOM32)

Summary of the evidence on oral mycophenolate for systemic sclerosis (scleroderma) to inform local NHS planning and decision-making

Evidence summary Published July 2014

Research recommendations

CG114/1 | Intravenous iron in children:- A prospective study of adequate duration of intravenous iron preparations in...

Published April 2016 Last updated April 2016

Generalised anxiety disorder: quetiapine (ESUOM12)

Summary of the evidence on quetiapine monotherapy for treating generalised anxiety disorder (GAD) to inform local NHS planning and decision-making

Evidence summary Published May 2013

Lumacaftor–ivacaftor for treating cystic fibrosis homozygous for the F508del mutation (TA398)

Evidence-based recommendations on lumacaftor–ivacaftor (Orkambi) for treating cystic fibrosis in people 12 years and older who are homozygous for the F508del..

Technology appraisal guidance Published July 2016

Systemic lupus erythematosus: oral mycophenolate (ESUOM36)

Summary of the evidence on oral mycophenolate for systemic lupus erythematosus (SLE) to inform local NHS planning and decision-making

Evidence summary Published November 2014

NICE autism quality standard will help tackle 'real variation in care'

NICE's new quality standard on autism will help services address the current variation in diagnosis and treatment of the disorder, according to experts.

News Published January 2014 Last updated January 2014

NICE responds to feedback on eating disorders quality initiatives

A new NICE quality standard (QS) on eating disorders focuses on promoting early access and coordinating care between services.

News Published September 2018 Last updated September 2018

More support needed for carers of people with bipolar disorder

More support should be to be given to carers of people with bipolar disorder to help them cope with challenging behaviour, says NICE.

News Published September 2014 Last updated September 2014

New treatment approved for adolescents with bipolar disorder

NICE has recommended the use of aripiprazole (Abilify) as an option for treating moderate to severe manic episodes in adolescents with bipolar disorder.

News Published July 2013 Last updated July 2013